About Qureight.

Our mission is to accelerate clinical trial development at key decision points through data curation and AI-powered decision making. We work with pharmaceutical companies, contract research organisations and hospitals to curate data and help the best drugs get approved so they can be given to patients with lung and heart diseases who need them.

Management Team

Dr. Muhunthan Thillai

Chief Executive Officer & Co-Founder

Muhunthan has over 20 years experience in thoracic medicine and is a board certified Pulmonologist. He qualified as a doctor from Imperial College London and undertook specialist medical training in Oxford where he was appointed as a member of the Royal College of Physicians. He was awarded a PhD in molecular immunology from Imperial College London before being appointed as a consultant physician. He was previously Director of Interstitial Lung Diseases at Royal Papworth and Addenbrooke’s Hospitals Cambridge UK and is currently an Honorary Associate Professor at the University of East Anglia.

Dr. Alessandro Ruggiero

Chief Scientific Officer & Co-Founder

Alessandro has expertise in lung and heart imaging and is a board certified Radiologist. He qualified as a doctor at the University of Rome and undertook a Molecular Imaging for Oncology Fellowship at Memorial Sloan Kettering Cancer Center (New York, USA). He was awarded a PhD from Erasmus University Medical Center in Rotterdam and was previously Director of radiology research at Royal Papworth Hospital Cambridge UK.

Darren Gallagher

Chief Technical Officer

Darren has a wealth of experience in the software industry with a background in big data and distributed systems. His previous roles have included Head of Engineering at Autonomy and Director of Engineering, Big Data at Hewlett Packard Enterprise. He has developed software and managed teams from large multinationals to start ups. He is experienced in growing technology infrastructure and teams from pre-seed stage through to product launch and beyond.

Scientific Advisory Board

Principal - Open Innovation Solutions for Precision Medicine
Iqvia
Keck School of Medicine of the University of Southern California
Imperial College London
British Lung Foundation Professor
Imperial College London
Industry Expert
Industry Expert
Wythenshawe Hospital

Board of Directors

Chief Executive Officer
Chief Scientific Officer
Investment Director
Investment Director
Board Observer
Board Observer
Non-Executive Director

Investors